What Researchers Did
A clinical team at an Australian hospital described the governance, risk management, and operational steps they used to deliver 13 HBOT sessions to a critically ill patient on a venovenous ECMO machine, a first-of-its-kind procedure globally.
What They Found
Through a 32-hour approval process involving ethics review, legal consultation, clinical innovation committees, and executive sign-off, the team safely delivered all 13 HBOT sessions to a patient with severe fungal infection and no remaining treatment options. A validated ECMO device, purpose-built checklists, and dedicated staffing made the procedure feasible.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a single case report, the safety and feasibility findings cannot be generalized without larger studies.